Mark Agulnik, MD

Professor of Clinical Medicine

Vice Chair for Faculty Development, Department of Medicine

Section Chief of Sarcomas & Melanoma

Is this your profile? Click to edit

Request an Appointment

Publications

SMARCA4 / BRG1 -deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4 -driven Gynecologic Malignancies. Int J Gynecol Pathol. 2024 Jul 01; 43(4):354-361.. View in PubMed
Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma. J Pers Med. 2023 Oct 15; 13(10).. View in PubMed
Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor. Gynecol Oncol Rep. 2023 Dec; 50:101294.. View in PubMed
State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities. JCO Oncol Pract. 2023 11; 19(11):959-966.. View in PubMed
Role of immunotherapy in chondrosarcoma: A case report and review of the literature. Ther Adv Med Oncol. 2023; 15:17588359231199877.. View in PubMed
Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted? Head Neck. 2023 08; 45(8):2079-2086. Vo K, Ladbury C, Tam A, Ma . View in PubMed
Surgical Management of Retroperitoneal Sarcoma. Curr Oncol. 2023 04 29; 30(5):4618-4631.. View in PubMed
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma. J Clin Med. 2023 Mar 29; 12(7).. View in PubMed
Targeted therapies for the treatment of soft tissue sarcoma. Front Oncol. 2023; 13:1122508.. View in PubMed
Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma. Front Oncol. 2023; 13:1123464.. View in PubMed

Mark Agulnik, MD

Publications

Similar People